Liu X J, Cui Z J, Zhang S T, Su W G, Meng Q N, Guo P F, Wei A Z, Zhou J, Wang C Y, Zou S B, Sun J L, Wang X
Department of Burns and Repair Reconstruction, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
Zhonghua Shao Shang Za Zhi. 2020 Dec 20;36(12):1191-1198. doi: 10.3760/cma.j.cn501120-20190930-00390.
To compare the efficacy and safety of triamcinolone acetonide (TA) alone and in combination with 5-fluorouracil (5-FU) for treating keloids using meta-analysis. Databases including and were retrieved with the search terms of " triamcinolone acetonide, 5-fluorouracil, glucocorticoid, fluorouracil, keloid, scar, TAC, 5-FU, hypertrophic scar " and databases including - and were retrieved with the search terms of ",, 5-,," in Chinese to obtain the publicly published randomized controlled trials about the effects of TA alone and in combination with 5-fluorouracil for treating keloids from the establishment of each database to august 2019. The outcome indexes included effective proportion of treatment, incidence proportion of adverse reactions, and recurrence proportion of keloids. RevMan 5.3 and Stata 14.0 statistical software were used to conduct a meta-analysis of eligible studies. A total of 1 326 patients with keloids were included in 14 studies, including 668 patients in TA+ 5-fluorouracil group whose keloids were injected with TA and 5-fluorouracil and 658 patients in TA alone group whose keloids were injected with TA alone. A total of 7 articles achieved 1 to 3 points in modified Jadad score, while 7 articles achieved 4 to 7 points in modified Jadad score. Patients in TA+ 5-fluorouracil group had a higher effective proportion of treatment than that of TA alone group (relative risk=1.28, 95% confidence interval=1.16-1.41, <0.01). Subgroup analysis showed that the quality of the included literature and ethnic factors might be the source of heterogeneity in effective proportion of treatment. Patients in TA+ 5-fluorouracil group had a lower incidence proportion of adverse reactions than that of TA alone group (relative risk=0.44, 95% confidence interval=0.25-0.75, <0.01). Patients in TA+ 5-fluorouracil group had a lower recurrence proportion of keloids than that of TA alone group (relative risk=0.25, 95% confidence interval=0.14-0.44, <0.01). There was no publication bias in incidence proportion of adverse reactions (>0.05), while the effective proportion of treatment and recurrence proportion of keloids had publication bias (<0.05). TA combined with 5-fluorouracil is more effective than TA alone for treating keloids, with less incidence of adverse reactions and recurrence.
采用Meta分析比较曲安奈德(TA)单独及联合5-氟尿嘧啶(5-FU)治疗瘢痕疙瘩的疗效和安全性。以“曲安奈德、5-氟尿嘧啶、糖皮质激素、氟尿嘧啶、瘢痕疙瘩、瘢痕、曲安奈德联合5-氟尿嘧啶、5-氟尿嘧啶、增生性瘢痕”为检索词检索包括 和 在内的数据库,以中文检索词“曲安奈德、5-氟尿嘧啶、糖皮质激素、氟尿嘧啶、瘢痕疙瘩、瘢痕、曲安奈德联合5-氟尿嘧啶、5-氟尿嘧啶、增生性瘢痕”检索包括 - 和 在内的数据库,获取各数据库建库至2019年8月公开发表的关于TA单独及联合5-氟尿嘧啶治疗瘢痕疙瘩的随机对照试验。结局指标包括治疗有效率、不良反应发生率、瘢痕疙瘩复发率。采用RevMan 5.3和Stata 14.0统计软件对纳入的研究进行Meta分析。14项研究共纳入1326例瘢痕疙瘩患者,其中TA+5-氟尿嘧啶组668例,瘢痕疙瘩内注射TA和5-氟尿嘧啶;TA单独组658例,瘢痕疙瘩内仅注射TA。共7篇文章改良Jadad评分达1~3分,7篇文章改良Jadad评分达4~7分。TA+5-氟尿嘧啶组患者的治疗有效率高于TA单独组(相对危险度=1.28,95%置信区间=1.16~1.41,<0.01)。亚组分析显示,纳入文献的质量和种族因素可能是治疗有效率异质性的来源。TA+5-氟尿嘧啶组患者的不良反应发生率低于TA单独组(相对危险度=0.44,95%置信区间=0.25~0.75,<0.01)。TA+5-氟尿嘧啶组患者的瘢痕疙瘩复发率低于TA单独组(相对危险度=0.25,95%置信区间=0.14~0.44,<0.01)。不良反应发生率无发表偏倚(>0.05),而治疗有效率和瘢痕疙瘩复发率存在发表偏倚(<0.05)。TA联合5-氟尿嘧啶治疗瘢痕疙瘩比TA单独治疗更有效,不良反应和复发发生率更低。